NCT06830590View on ClinicalTrials.gov

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

December 30, 2025

Study Completion Date

December 31, 2025

Conditions
Breast CancerMolecular Pathway DeregulationTreatment
Interventions
PROCEDURE

Molecular characterisation

All patients treated by surgery were included without any neoadjuvant therapy

Trial Locations (1)

Unknown

RECRUITING

Binafsha M Syed, Jamshoro

All Listed Sponsors
lead

Liaquat University of Medical & Health Sciences

OTHER

NCT06830590 - Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population | Biotech Hunter | Biotech Hunter